Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Megestrol + ibuprofen for cancer cachexia

Oct. 21, 1997

First launch for Yamanouchi bisphosphonate

Oct. 21, 1997

FDA approves Follistim for IVF and ovulation induction

Oct. 17, 1997

Abbott and Biorex to collaborate on bimoclomol development

Oct. 17, 1997

Novel protein tyrosine kinase inhibitors particularly useful for osteoporosis

Oct. 16, 1997

Clinical activity of policosanol reported

Oct. 16, 1997

Niaspan clinical activity reported at atherosclerosis symposium

Oct. 16, 1997

Lipogelosomes: a novel approach to lowering cholesterol

Oct. 16, 1997

Preclinical cholesterol-lowering efficacy described for FR-194738

Oct. 16, 1997

Fujisawa's benzimidazole derivatives have broad therapeutic potential

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...